TITLE

BIOCUREX/GOSHEN CANCER CENTER DEVELOPING RECAF

PUB. DATE
July 2005
SOURCE
Worldwide Biotech;Jul2005, Vol. 17 Issue 7, p5
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Repots on the collaboration of BioCurex Inc. with the Center for Cancer Care in Goshen, Indiana for developing and evaluating its RECAF technology, as of July 2005. Details of the collaboration; Significance of the move in delivering therapeutic agents to destroy the cancer cells with minimal damage to normal tissues; Statement issued by Douglas Schwartzentruber, medical director of Goshen Health System's Center for Cancer Care, about the partnership.
ACCESSION #
17706735

 

Related Articles

  • Douglas Schwartzentruber and Larry Kwak. Shanteau, Eric // Time International (Atlantic Edition);5/10/2010, Vol. 175 Issue 18, p63 

    The article profiles medical researchers Douglas Schwartzentruber and Larry Kwak, both of whom are working to develop a cancer vaccine.

  • Douglas Schwartzentruber and Larry Kwak. Shanteau, Eric // Time;5/10/2010, Vol. 175 Issue 18, p107 

    The article profiles medical researchers Douglas Schwartzentruber and Larry Kwak, both of whom are working to develop a cancer vaccine.

  • Blood: miR loss may power maligant transformation in chronic leukemia.  // Biomedical Market Newsletter;7/19/2012, Vol. 21, p1 

    The article discusses a study by the researchers of the Ohio State University Medical Center which shows that miR-125b molecule is lost in chronic lymphocytic leukemia associated with a characteristic ofcancer cells including Warburg effect.

  • ZIOPHARM Announces Initial Positive Data Presented at 2011 ASCO Annual Meeting from First-Ever Treatment Demonstrating Small Molecule-Controlled Production of Anticancer Protein in Humans.  // Biomedical Market Newsletter;6/9/2011, p520 

    The article focuses on the announcment of Ziopharm Oncology Inc. on the initial positive clinical results of ZIN-CTI-001 phase Ib study presented by doctor Douglas J. Schwartzentruber on a session during the 2011 American Society of Clinical Oncology (ASCO) Annual Meeting. It states that the...

  • ZIOPHARM Oncology to Present Data at 2011 ASCO Annual Meeting from First-Ever Treatment Demonstrating Small Molecule-Controlled Production of Anticancer Protein in Humans.  // Biomedical Market Newsletter;5/17/2011, p208 

    The article reports the presentation of Ziopharm Oncology Inc. at the 2011 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held in Chicago, Illinois from June 3-7. It states that representative Douglas J. Schwartzentruber will discuss the results of the Phase Ib...

  • First blood test unveiled for cancer detection in dogs.  // DVM: The Newsmagazine of Veterinary Medicine;Apr2010, Vol. 41 Issue 4, p12 

    A preview of the OncoPet RECAF Blood TEST, the first cancer detecting method for dogs, from BioCurex Inc. is presented.

  • Cancer-Killing Virus Raises Hopes.  // Nutrition Health Review: The Consumer's Medical Journal;2004, Issue 92, p15 

    This article reports that according to investigators at Perm State College of Medicine, six days is all it takes for a common, non-disease-causing virus to kill epithelial cancer cells in laboratory cultures. Their results suggest that adeno-associated virus type 2, which infects the majority of...

  • New apoptosis drugs face critical test. Garber, Ken // Nature Biotechnology;Apr2005, Vol. 23 Issue 4, p409 

    The article focuses on the critical testing of a new apoptosis drug in the U.S. A startup company Joyant Pharmaceuticals in Dallas, Texas, licensed some anticancer compounds from the University of Texas-Southwestern (UTSW). In a September 2004 paper in the journal "Science", UTSW investigators...

  • Agreements.  // Medical Device Daily;2/15/2008, Vol. 12 Issue 32, p5 

    The article reports on the decision of Waters and Vanderbilt University Medical Center (VUMC) that they will pursue collaborative research using Waters Maldi Synapt High Definition MS System for enhanced tissue imaging capabilities for oncology research within the university's Mass Spectrometry...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics